Literature DB >> 27898388

Impact of HbA1c Testing at Point of Care on Diabetes Management.

Oliver Schnell1, J Benjamin Crocker2, Jianping Weng3.   

Abstract

Diabetes is a highly prevalent disease also implicated in the development of several other serious complications like cardiovascular or renal disease. HbA1c testing is a vital step for effective diabetes management, however, given the low compliance to testing frequency and, commonly, a subsequent delay in the corresponding treatment modification, HbA1c at the point of care (POC) offers an opportunity for improvement of diabetes care. In this review, based on data from 1999 to 2016, we summarize the evidence supporting a further implementation of HbA1c testing at POC, discuss its limitations and propose recommendations for further development.

Entities:  

Keywords:  HbA1c testing; diabetes management; glycemic control; point-of-care

Mesh:

Substances:

Year:  2016        PMID: 27898388      PMCID: PMC5505423          DOI: 10.1177/1932296816678263

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  62 in total

1.  Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care.

Authors: 
Journal:  Diabet Med       Date:  2006-06       Impact factor: 4.359

2.  Effect of point-of-care on maintenance of glycemic control as measured by A1C.

Authors:  John R Petersen; Jane B Finley; Anthony O Okorodudu; Amin A Mohammad; James J Grady; Mandeep Bajaj
Journal:  Diabetes Care       Date:  2007-03       Impact factor: 19.112

3.  Point-of-care assays for hemoglobin A(1c): is performance adequate?

Authors:  Randie R Little; Erna Lenters-Westra; Curt L Rohlfing; Robbert Slingerland
Journal:  Clin Chem       Date:  2011-06-28       Impact factor: 8.327

4.  Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.

Authors:  David B Sacks; Mark Arnold; George L Bakris; David E Bruns; Andrea Rita Horvath; M Sue Kirkman; Ake Lernmark; Boyd E Metzger; David M Nathan
Journal:  Diabetes Care       Date:  2011-06       Impact factor: 19.112

5.  Evaluation of Three Hemoglobin A1c Point-of-Care Instruments.

Authors:  Marieke Criel; Stijn Jonckheere; Michel Langlois
Journal:  Clin Lab       Date:  2016       Impact factor: 1.138

6.  Patient satisfaction with point-of-care testing in general practice.

Authors:  Caroline O Laurence; Angela Gialamas; Tanya Bubner; Lisa Yelland; Kristyn Willson; Phil Ryan; Justin Beilby
Journal:  Br J Gen Pract       Date:  2010-03       Impact factor: 5.386

7.  Rapid A1c availability improves clinical decision-making in an urban primary care clinic.

Authors:  Christopher D Miller; Catherine S Barnes; Lawrence S Phillips; David C Ziemer; Daniel L Gallina; Curtiss B Cook; Sandra D Maryman; Imad M El-Kebbi
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

8.  Diabetes management in the real world and the impact of adherence to guideline recommendations.

Authors:  Jean Lian; Yuanjie Liang
Journal:  Curr Med Res Opin       Date:  2014-08-29       Impact factor: 2.580

9.  Five steps to conducting a systematic review.

Authors:  Khalid S Khan; Regina Kunz; Jos Kleijnen; Gerd Antes
Journal:  J R Soc Med       Date:  2003-03       Impact factor: 18.000

10.  Comparability of hemoglobin A1c level measured in capillary versus venous blood sample applying two point-of-care instruments.

Authors:  Tahereh Keramati; Farideh Razi; Ali Tootee; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2014-10-30
View more
  17 in total

1.  Evaluation of Point of Care Analyzer for Hemoglobin A1c.

Authors:  Anne Marie Dupuy; Stéphanie Badiou; Anne Sophie Bargnoux; Jennifer Russelo; Jean Paul Cristol
Journal:  J Diabetes Sci Technol       Date:  2018-11-27

2.  Evaluation of Four HbA1c Point-of-Care Devices Using International Quality Targets: Are They Fit for the Purpose?

Authors:  Erna Lenters-Westra; Emma English
Journal:  J Diabetes Sci Technol       Date:  2018-06-19

3.  Implementation of HbA1c Point of Care Testing in 3 German Medical Practices: Impact on Workflow and Physician, Staff, and Patient Satisfaction.

Authors:  Karl-Heinz Patzer; Payam Ardjomand; Katharina Göhring; Guido Klempt; Andreas Patzelt; Markus Redzich; Mathias Zebrowski; Susanne Emmerich; Oliver Schnell
Journal:  J Diabetes Sci Technol       Date:  2018-03-13

4.  High-frequency HbA1c testing among older patients with diabetes in Japan: a longitudinal analysis using medical claims data.

Authors:  Ning Liu; Yoshihisa Fujino; Kenji Fujimoto; Makoto Ohtani; Hanaka Imamura; Shinya Matsuda
Journal:  Diabetol Int       Date:  2022-05-09

5.  Avocado Consumption for 12 Weeks and Cardiometabolic Risk Factors: A Randomized Controlled Trial in Adults with Overweight or Obesity and Insulin Resistance.

Authors:  Xuhuiqun Zhang; Di Xiao; Gabriela Guzman; Indika Edirisinghe; Britt Burton-Freeman
Journal:  J Nutr       Date:  2022-08-09       Impact factor: 4.687

6.  Clinical Findings in Diabetes Mellitus Patients with COVID-19.

Authors:  Ting Guo; Qinxue Shen; Xiaoli Ouyang; Wei Guo; Jinhua Li; Wenlong He; Bo Yu; Chenfang Wu; Zhiguo Zhou; Hong Luo; Hong Peng
Journal:  J Diabetes Res       Date:  2021-01-08       Impact factor: 4.011

7.  Patient Satisfaction and Clinical Efficacy of Novel Blood Glucose Meters Featuring Color Range Indicators in Patients With Type 2 Diabetes: A Prospective Study.

Authors:  Ayman Al Hayek; Asirvatham Alwin Robert; Mohamed Al Dawish
Journal:  Cureus       Date:  2020-10-27

8.  Role and Risk Factors of Glycosylated Hemoglobin Levels in Early Disease Screening.

Authors:  Guanqun Chao; Yue Zhu; Liying Chen
Journal:  J Diabetes Res       Date:  2021-04-08       Impact factor: 4.011

Review 9.  Detection of Early Disease Risk Factors Associated with Metabolic Syndrome: A New Era with the NMR Metabolomics Assessment.

Authors:  Julia Hernandez-Baixauli; Sergio Quesada-Vázquez; Roger Mariné-Casadó; Katherine Gil Cardoso; Antoni Caimari; Josep M Del Bas; Xavier Escoté; Laura Baselga-Escudero
Journal:  Nutrients       Date:  2020-03-18       Impact factor: 5.717

10.  Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis via AMPK and mTOR regulation.

Authors:  David Fernández-Ramos; Fernando Lopitz-Otsoa; Laura Delacruz-Villar; Jon Bilbao; Martina Pagano; Laura Mosca; Maider Bizkarguenaga; Marina Serrano-Macia; Mikel Azkargorta; Marta Iruarrizaga-Lejarreta; Jesús Sot; Darya Tsvirkun; Sebastiaan Martijn van Liempd; Felix M Goni; Cristina Alonso; María Luz Martínez-Chantar; Felix Elortza; Liat Hayardeny; Shelly C Lu; José M Mato
Journal:  World J Gastroenterol       Date:  2020-09-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.